Cargando…
Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044834/ https://www.ncbi.nlm.nih.gov/pubmed/35473511 http://dx.doi.org/10.1186/s12885-022-09593-2 |
_version_ | 1784695189059665920 |
---|---|
author | Zhou, Wen Ma, Junjun Meng, Lifeng Liu, Dabei Chen, Jun |
author_facet | Zhou, Wen Ma, Junjun Meng, Lifeng Liu, Dabei Chen, Jun |
author_sort | Zhou, Wen |
collection | PubMed |
description | BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles homolog 3 (TRIB3) dependent manner. RESULT: Integrin αvβ3 could mediate the activation of FAK/AKT pro-survival signaling pathway. Meanwhile, activated TRIB3 interacted with AKT to upregulated FOXO1 and SOX2 expression, resulting in sustained tumor progression in lung cancer. Our further analysis revealed that TRIB3 was significantly upregulated in lung tumor tissues and correlated with the poor outcome in clinical patients, indicating the potential role of TRIB3 in diagnostic and prognostic estimation for patients with lung cancer. CONCLUSION: Our study showed here for the first time that integrin αvβ3 promote lung cancer development by activating the FAK/AKT/SOX2 axis in a TRIB3 dependent signaling pathway, and interrupting TRIB3/AKT interaction significantly improved the outcome of chemotherapy in tumor-bearing mice, representing a promising therapeutic strategy in lung cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09593-2. |
format | Online Article Text |
id | pubmed-9044834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90448342022-04-28 Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer Zhou, Wen Ma, Junjun Meng, Lifeng Liu, Dabei Chen, Jun BMC Cancer Research BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles homolog 3 (TRIB3) dependent manner. RESULT: Integrin αvβ3 could mediate the activation of FAK/AKT pro-survival signaling pathway. Meanwhile, activated TRIB3 interacted with AKT to upregulated FOXO1 and SOX2 expression, resulting in sustained tumor progression in lung cancer. Our further analysis revealed that TRIB3 was significantly upregulated in lung tumor tissues and correlated with the poor outcome in clinical patients, indicating the potential role of TRIB3 in diagnostic and prognostic estimation for patients with lung cancer. CONCLUSION: Our study showed here for the first time that integrin αvβ3 promote lung cancer development by activating the FAK/AKT/SOX2 axis in a TRIB3 dependent signaling pathway, and interrupting TRIB3/AKT interaction significantly improved the outcome of chemotherapy in tumor-bearing mice, representing a promising therapeutic strategy in lung cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09593-2. BioMed Central 2022-04-26 /pmc/articles/PMC9044834/ /pubmed/35473511 http://dx.doi.org/10.1186/s12885-022-09593-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhou, Wen Ma, Junjun Meng, Lifeng Liu, Dabei Chen, Jun Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title | Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title_full | Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title_fullStr | Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title_full_unstemmed | Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title_short | Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
title_sort | deletion of trib3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044834/ https://www.ncbi.nlm.nih.gov/pubmed/35473511 http://dx.doi.org/10.1186/s12885-022-09593-2 |
work_keys_str_mv | AT zhouwen deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer AT majunjun deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer AT menglifeng deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer AT liudabei deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer AT chenjun deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer |